New Study Further Indicates Health-Promoting Capabilities

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
New Study Further Indicates Health-Promoting Capabilities of MGP’s Fibersym® RW Resistant Wheat Starch

ATCHISON, Kan., Sept. 15, 2016 (GLOBE NEWSWIRE) -- Results of a new study further support the health-promoting role that MGP’s Fibersym® RW, a patented Non-GMO Project Verified resistant wheat starch, can perform as a dietary fiber source.

Conducted independently at South Dakota State University (SDSU), the 12-week study showed that Fibersym RW and butyrate, which is produced by fermentation of resistant starch by the gut bacteria, may function as an epigenetic repressor of pro-inflammatory genes.  Epigenetics can be defined as the study of changes in an organism’s gene activity, which are not caused by alterations in underlying DNA sequences or genetic code.

According to Moul Dey, Ph.D., associate professor of health and nutritional sciences at SDSU and lead investigator for the project, “Everyone is born with a genetic blueprint that rarely changes during their lifetime.  But diet and environment can epigenetically change how genes function without changing the genetic code.  While epigenetic mechanisms are complex, this pilot study is a stepping stone to future mechanistic research to understand how resistant starch may impart various health benefits that we have previously reported.”

This newest study, the third conducted on Fibersym RW at SDSU, “substantiates earlier findings demonstrating the positive health and butyrogenic effects of Fibersym® RW,” said Ody Maningat, Ph.D., vice president of R&D and chief science officer at MGP.  “It adds to the wealth of scientific evidence supporting the beneficial physiological effects of Fibersym RW in humans.  These include lowering of total blood cholesterol levels, lowering of post-prandial glucose levels, reduction of waist circumference and body fat percentage with possible associated obesity reduction outcomes, increased colonic fermentation/short-chain fatty acid production and positive modulation of colonic microflora.”

Mike Buttshaw, vice president of ingredients sales and marketing at MGP, added, “Studies like this one make a highly appealing case for Fibersym RW in the marketplace because dietary fiber resonates so well with consumers.  According to the International Food Information Council, fiber ranked second in the list of most consumed nutrients in 2015 and 2016.”

Completed over the summer, the study investigated in vivo effects of Fibersym RW on butyrate production in the cecum and butyrate-associated regulation of inflammatory markers of colon tissues in mice.  Six-week old male mice were grouped randomly to consume either a Fibersym RW diet or a control diet, both diets being isocaloric.  At the conclusion of the feeding period, cecal samples were analyzed and showed that butyrate concentration was twice as high in the Fibersym RW group than in the control group.  Analysis of mouse colon tissues, as well as colon cells of human origin, revealed the repression of pro-inflammatory mediators indicating that Fibersym RW may have an anti-inflammatory role.

Titled “Dietary resistant starch type 4-derived butyrate attenuates nuclear factor-kappa-B1 through modulation of histone H3 trimethylation at lysine 27,” the study was published in Food & Function (DOI: 10.1039c6fo00856a) on August 9, 2016.

For additional details about Fibersym RW, visit mgpingredients.com/fibersym .

About MGP Celebrating its 75 th anniversary, MGP (Nasdaq: MGPI ) is a leading supplier of premium distilled spirits and specialty wheat proteins and starches. Distilled spirits include bourbon and rye whiskeys, gins and vodkas, which are carefully crafted through a combination of art and science backed by decades of experience. The company's proteins and starches are created in the same manner and provide a host of functional, nutritional and sensory benefits for a wide range of food products. MGP additionally is a top producer of high quality industrial alcohol for use in both food and non-food applications. The company is headquartered in Atchison, Kansas, where distilled alcohol products and food ingredients are produced. Premium spirits are also distilled and matured at the company’s facility in Lawrenceburg, Indiana.  For more information, visit mgpingredients.com .

Contact: Steve Pickman 913.367.1480 steve.pickman@mgpingredients.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Astemo Flexes Aftermarket Muscles at 2026 AAPEX & SEMA

Updated Category News Views 90

Ah, nothing gets car enthusiasts more revved up than a good old-fashioned auto show unveiling. Astemo Americas is strutting its stuff at the 2026 AAPEX and SEMA shows, and they're not just shooting the breeze—this company has got some serious aftermarket muscle to flex. Pumping Up the Aftermarket Game Astemo's not sitting on its hands when it comes to expanding its...

Continue Reading
Ping An Shows Resilient Growth Amid Economic Pressure

Updated Category News Views 18

Unpacking Ping An's Steady Climb Amid Tumult A few eyebrows might have raised when Ping An Insurance unveiled its nine-month report for 2026. Despite economic turbulence in China—courtesy of a gnarly global scene—the numbers were anything but rattled. Operating profit rose 8.3% year over year to a beefy RMB125,905 million. The equity pool swelled by 4.4% as of...

Continue Reading
Beacon AI's Murdock Flies into the Future for USAF

Updated Category News Views 69

Advancing AI in the Skies Nothing quite shakes up the aviation scene like a debut flight of a new AI system aboard real-deal military planes. Beacon AI is throwing down its AI pilot assistant system, Murdock, on the table—its pride and joy just completed five flights on KC-46A Pegasus craft, sanctioned by no less than the U.S. Air Force itself. Grit and Innovation: The...

Continue Reading
Lynk Pharmaceuticals' Zemprocitinib Shines in Phase III RA Trial

Updated Category News Views 86

A Deep Dive into Lynk Pharmaceuticals' Latest Revelation Lynk Pharmaceuticals just dropped a bombshell with their latest Phase III trial results for zemprocitinib. This selective JAK1 inhibitor seems to be bringing some serious game in the fight against moderate-to-severe rheumatoid arthritis (RA), especially for folks who haven't had much luck with biologics. The drug...

Continue Reading
Baystate Health's Pilot Eases Access to Medical Services

Updated Category News Views 98

Rethinking Healthcare Access with Baystate Health Now here's a bit of news that doesn't make you wanna choke on your coffee: Baystate Health's Clear Path Pilot Program is shaking things up in the healthcare game, and it's about time. The initiative, rolling out with Health New England, is like waving a magic wand over the usual bureaucratic mess of prior authorizations....

Continue Reading
Astellas and Audax Forge $1.34B Immuno-Oncology Deal

Updated Category News Views 100

Big Moves in Immuno-Oncology: Astellas' Latest Bet You hear 'immuno-oncology,' you think breakthrough, right? Well, friends, that's what Astellas and Audax Biosciences are shooting for with their fresh handshake over DAX-044. On October 27, 2026, in Tokyo and Melbourne, the two outfits announced they're joining forces to bring this novel immunotherapy to the table. It's...

Continue Reading
Singapore's New Leap in Healthcare Innovation with IMDA-NUH Partnership

Updated Category News Views 0

A Groundbreaking Partnership in Singapore's Healthcare Sector Every so often, something big comes along that makes you stop and take notice. This time, it's the alliance between the Infocomm Media Development Authority (IMDA) and the National University Hospital (NUH) in Singapore. By launching an Open Innovation Platform (OIP) partnership, they've embarked on a journey...

Continue Reading
OppFi's Q3 2026: Is Their Growth Strategy on Track?

Updated Category News Views 14

OppFi's Third Quarter Performance Unpacked OppFi's recent third-quarter disclosures should get investors pondering. They've launched a new line of credit product, plugging a gap in their service portfolio, and aimed to widen their customer net. Their targeted share repurchase of $6.7 million in stock isn't small potatoes either, showing a vote of confidence in their own...

Continue Reading
Lennox Faces Pressures Amidst Strong Revenue Growth

Updated Category News Views 0

Revenue Surge but Margin Squeeze Out there in the land of HVAC, Lennox International (NYSE: LII) just dropped its third quarter earnings for 2026. Sure, they raked in a solid $1.6 billion—up a hearty 10%. But all that glitters ain't gold, and the company's operating income took a hit down to $312 million, shedding a cool five percent from last year. Challenges Weighing...

Continue Reading
Digimon Card Game Ventures into Digital Realms

Updated Category News Views 40

A Bold Leap for the Digimon Card Game Folks, if you've been tapping your foot waiting for Digimon to fire up a serious digital game, well, here's your moment. BANDAI CO., LTD. is rolling the dice as they launch pre-registration for DIGIMON ALYSION, a digital twist on the classic card game, across 49 countries. It's not just a game; it's a reimagining. They're not just...

Continue Reading

Top 5 Most Recently Viewed Articles

Xinjiang's International Week Sparks Global Agricultural Talks

Updated Category News Views 22

Shihezi's Global Stage: A Week of Shared Opportunities Shihezi, tucked away in the far reaches of Xinjiang, China, has become a hub of global discourse this week. Here's the kicker—an International Week filled with events aiming to connect the dots between technological innovation and agricultural advancement kicked off on August 31. Look, they've got experts and...

Continue Reading
Essity's Strategic Buyback Program for Class B Shares

Updated Category News Views 189

Essity Aktiebolag Initiates Class B Share Buyback Essity Aktiebolag (publ) has taken a significant step in its growth strategy by repurchasing a total of 270,000 Class B shares. This decision, made between February 10 and February 14, 2025, marks a critical component of the company’s ongoing commitment to enhance shareholder value. Overview of the Buyback Program The...

Continue Reading
Exploring Opendoor's Stock Surge: Key Insights Unveiled

Updated Category News Views 137

Opendoor Technologies Inc Stock Performance Opendoor Technologies Inc (NASDAQ: OPEN) has been witnessing notable movement in the stock market recently, prompting investor interest. The company, known for its innovative approach to real estate, is adapting to new market conditions and strategic initiatives that are influencing its share prices positively. Support for...

Continue Reading
Market Challenges Impact Project Energy's Stock Performance

Updated Category News Views 50

Market Challenges Impact Project Energy Reimagined Acquisition Corp. In a striking indicator of the turbulent market landscape, Project Energy Reimagined Acquisition Corp. (PITA) has seen its stock plunge to a 52-week low, with shares dropping to a challenging $0.95. This significant decline reflects a severe downturn for PITA, characterized by a staggering one-year...

Continue Reading
Emergency Actions Following South Korea's Largest Airline Crash

Updated Category News Views 436

South Korea's Urgent Response to Air Disaster In a significant response to the aviation crisis, acting President Choi Sang-mok has mandated an immediate overhaul of South Korea's airline safety protocols. This decision came after the nation faced its deadliest air disaster, resulting in a tragic loss of 179 lives when a flight encountered catastrophic failure in landing....

Continue Reading